WuXi AppTec nets $950m from H-share tap
Chinese pharmaceutical company WuXi AppTec has raised HK$7.37bn ($950.4m) of fresh equity, in a hotly-anticipated tap of a new mandate to issue A-shares and H-shares.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: